Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Evolent Health ( (EVH) ) has issued an announcement.
On November 6, 2025, Evolent Health announced significant leadership changes, including the appointment of Mario Ramos as Chief Financial Officer effective January 1, 2026, and John Johnson transitioning to Chief Strategy Officer. These changes are aimed at supporting the company’s growth trajectory, particularly in oncology. Evolent also reported strong financial results for Q3 2025, with revenue exceeding expectations and new contracts expected to generate over $750 million in annualized revenue in 2026. The company is expanding its leadership team to manage accelerating growth and enhance its market position.
The most recent analyst rating on (EVH) stock is a Hold with a $7.50 price target. To see the full list of analyst forecasts on Evolent Health stock, see the EVH Stock Forecast page.
Spark’s Take on EVH Stock
According to Spark, TipRanks’ AI Analyst, EVH is a Neutral.
Evolent Health’s overall stock score is primarily impacted by its financial performance and technical analysis. The company faces significant challenges with declining revenues and persistent losses, which are reflected in its financial metrics. The technical indicators suggest a bearish trend, further weighing on the stock’s outlook. While the earnings call highlighted positive developments in partnerships and AI advancements, these factors are not enough to offset the current financial and technical weaknesses.
To see Spark’s full report on EVH stock, click here.
More about Evolent Health
Evolent Health, Inc. specializes in improving health outcomes for individuals with complex conditions by offering solutions that simplify and make healthcare more affordable. The company focuses on providing specialty care solutions and has a strong presence in the healthcare industry, particularly in oncology and risk-based contracting.
Average Trading Volume: 3,036,133
Technical Sentiment Signal: Sell
Current Market Cap: $762.6M
For detailed information about EVH stock, go to TipRanks’ Stock Analysis page.